Literature DB >> 14011000

Measles antibodies in multiple sclerosis.

J M ADAMS, D T IMAGAWA.   

Abstract

Entities:  

Keywords:  ANTIBODIES; ENCEPHALITIS; MEASLES; MULTIPLE SCLEROSIS

Mesh：

Substances：

Year:  1962        PMID： 14011000     DOI： 10.3181/00379727-111-27855

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  83 in total

1.  Surface markers on lymphocytes of multiple sclerosis patients.

Authors:  J Nowak; A Wajgt
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

2.  INFECTIVE AGENTS AND MULTIPLE SCLEROSIS.

Authors:  C A ROSS; J A LENMAN; C RUTTER
Journal:  Br Med J       Date:  1965-01-23

3.  CLINICAL STUDIES OF MULTIPLE SCLEROSIS IN ISRAEL. II. A COMPARISON BETWEEN EUROPEAN AND AFRO-ASIAN PATIENTS.

Authors:  M ALTER; U LEIBOWITZ; L HALPERN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-12       Impact factor: 10.154

4.  METHODS OF DETERMINING IMMUNITY, DURATION AND CHARACTER OF IMMUNITY RESULTING FROM MEASLES.

Authors:  G ENDERS-RUCKLE
Journal:  Arch Gesamte Virusforsch       Date:  1965

5.  EVALUATION OF MULTIPLE SCLEROSIS SERA AGAINST MEASLES ANTIGEN IN THE COMPLEMENT FIXATION TEST.

Authors:  E PETTE; E KUWERT
Journal:  Arch Gesamte Virusforsch       Date:  1965

6.  Measles-virus-specific IgG in optic neuritis and in multiple sclerosis after optic neuritis.

Authors:  W M Hutchinson; M Haire
Journal:  Br Med J       Date:  1976-01-10

7.  The use of a measles latex reagent for the determination of measles antibodies and in a specific test for multiple sclerosis.

Authors:  T F Wild; G Quash; R Warocquier; F Cathala; J Huppert
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

8.  Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.

Authors:  J R Kateley; S J Bazzell
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

9.  Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis.

Authors:  P A Neighbour; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

10.  Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections.

Authors:  D C Poskanzer; J L Sever; J L Sheridan; L B Prenney
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.